Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05692245 · ClinicalTrials.gov registry record · Phase 4

Dexamethasone vs Ondansetron After Cesarean Delivery

A Phase 4 study of Cesarean Section Complications and Nausea and Vomiting, Postoperative, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target
1
Study location

NCT05692245 is a Phase 4 study of Cesarean Section Complications and Nausea and Vomiting, Postoperative that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants, below the 762-participant average among 9 other Cesarean Section Complications trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05692245, a Phase 4 study of Cesarean Section Complications and Nausea and Vomiting, Postoperative, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare medications in women having a cesarean delivery. The main question it aims to answer are: • Which medication is better to use as a first-line prevention agent for nausea and vomiting Participants will rate their nausea, pain and other symptoms after surgery Researchers will compare two drugs, ondansetron and dexamethasone to see if the side effects of pain medications are improved after cesarean.

Conditions Studied

Cesarean Section Complications Nausea and Vomiting, Postoperative

Interventions

  • DRUG Dexamethasone
  • DRUG Ondansetron

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-03-30
Est. Completion 2024-04-30
Phase Phase 4

Sponsor

Beth Israel Deaconess Medical Center

488 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05692245

The ClinicalTrials.gov registry entry for NCT05692245 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 762-participant average among 9 other Cesarean Section Complications trials with a reported enrollment target (87% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cesarean Section Complications appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.

NCT05692245 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05692245 about?

NCT05692245 is a clinical study titled "Dexamethasone vs Ondansetron After Cesarean Delivery". The goal of this clinical trial is to compare medications in women having a cesarean delivery. The main question it aims to answer are: • Which medication is better to use as a first-line prevention agent for nausea and vomiting Participants will rate their nausea, pain and other symptoms after sur...

What is the current status of trial NCT05692245?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2023-03-30. Estimated completion is 2024-04-30.

What conditions does trial NCT05692245 study?

This clinical trial studies the following conditions: Cesarean Section Complications, Nausea and Vomiting, Postoperative.

What interventions are being tested in trial NCT05692245?

The interventions under investigation include: Dexamethasone (DRUG), Ondansetron (DRUG).

Who is sponsoring clinical trial NCT05692245?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05692245 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cesarean Section Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cesarean Section Complications

All registered trials for this condition

Nausea and Vomiting, Postoperative

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.